Novocure (NVCR) Misses Q1 EPS by 18c

Novocure (NASDAQ: NVCR) reported Q1 EPS of ($0.50), $0.18 worse than the analyst estimate of ($0.32). Revenue for the quarter came in at $122.2 million versus the consensus estimate of $127.37 million.

For earnings history and earnings-related data on Novocure (NVCR) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• TD Cowen Reiterates Buy Rating on NVIDIA (NVDA), 'unlikely to move significantly on earnings'
• The free USDA tool that tracks egg prices at $0.62/dozen before your data vendor does